A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite ™ in Subjects With Scabies
Condition: Scabies Intervention: Drug: Permethrin Cream 5% Sponsors: bioRASI, LLC; Saptalis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2019 Category: Research Source Type: clinical trials
Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia
DiscussionDespite the apparent urgency, the key operational elements of proposed malaria elimination strategies in Southeast Asian mobile and migrant populations, including the Military, have yet to be rigorously tested in a well-controlled clinical study. Here, we present a protocol for the primary evaluation of two treatment paradigms – monthly malaria prophylaxis and focused screening and treatment – to achieve malaria elimination in a Cambodian military population. We will also assess the feasibility and incremental benefit of outdoor-biting vector intervention – permethrin-treated clothing. In the process, we ai...
Source: Trials - October 16, 2018 Category: Research Source Type: clinical trials
Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies
Condition: Scabies Interventions: Drug: Permethrin; Drug: Elimite 5% Cream Sponsors: Encube Ethicals Pvt. Ltd.; Novum Pharmaceutical Research Services Active, not recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2017 Category: Research Source Type: clinical trials
